The report, published Nov. 1 in Nature Communications, followed 96 people hospitalized with COVID-19 in 2020 in New York City and New Haven, Conn. Researchers found most patients had low gut microbiome diversity with a full quarter dominated by a single type of bacteria. In 20 percent of patients, antibiotic-resistant bacteria were found migrating into the bloodstream, making the patients more susceptible to secondary infection.
“Our findings suggest that coronavirus infection directly interferes with the healthy balance of microbes in the gut, further endangering patients in the process,” study co-senior author Ken Cadwell, PhD, said. “Now that we have uncovered the source of this bacterial imbalance, physicians can better identify those patients with coronavirus who are most at risk of a secondary bloodstream infection.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
